Testosterone propionate is indicated for replacement therapy
in the male in conditions associated with symptoms of
deficiency or absence of endogenous testosterone.
TRENBOLONE HEXAHYDROBENZYLCARBONATE
Pharmaceutical Form
Strengths
Therapeutic Category
Injectable
100 mg/ml
Trenbolone hexahydrobenzylcarbonate is used to treat weight gain
following extensive surgery, chronic infection, or severe trauma. It is
also used to minimize muscle dystrophy caused by treatment with
corticosteroids and to reduce bone pain caused by osteoporosis.
METHENOLONE ENANTHATE
Pharmaceutical Form
Strengths
Therapeutic Category
Injectable
100 mg/ml
Methenolone enanthate is indicated for treatment of
aplastic anemia, breast cancer, and postmenopausal
osteoporosis.
STANOZOLOL
Pharmaceutical Form
Strengths
Therapeutic Category
Injectable
50 mg/ml
Stanozolol is indicated for treatment of aplastic anemia and
hereditary angioedema. It has also been indicated as an
adjunct therapy for the treatment of various other medical
conditions such as vascular disorders and growth failure.
NANDROLONE PHENYLPROPIONATE
Pharmaceutical Form
Strengths
Therapeutic Category
Injectable
100 mg/ml
Nandrolone phenylpropionate is indicated for
management of the anemia of renal insufficiency and has
been shown to increase hemoglobin and red cell mass.
TESTOSTERONE CYPIONATE
Pharmaceutical Form
Strengths
Therapeutic Category
Injectable
250 mg/ml
Testosterone cypionate is indicated for replacement therapy
in the male in conditions associated with symptoms of
deficiency or absence of endogenous testosterone.
TRENBOLONE ACETATE
Pharmaceutical Form
Strengths
Therapeutic Category
Injectable
100 mg/ml
Trenbolone acetate is indicated for treatment of
androgen deficiency, wasting syndromes and
muscle atrophy, and certain types of anemia.
DROSTANOLONE PROPIONATE
Pharmaceutical Form
Strengths
Therapeutic Category
Injectable
100 mg/ml
Drostanolone propionate is indicated complex therapy for
some kind of tumors, particularly the ones associated
with hormone-active tissues like breast or prostate cancer.
BOLDENONE UNDECYLENATE
Pharmaceutical Form
Strengths
Therapeutic Category
Injectable
250 mg/ml
Boldenone undecylenate is indicated for consumptive
or debilitating type diseases that produce weight loss,
convalescent states, senile debility, rickets,
fractures and stress.
Cut mix is mainly used by athletes to gain muscle mass
and improve athletic performance.
TESTOSTERONE ENANTHATE
Pharmaceutical Form
Strengths
Therapeutic Category
Injectable
250 mg/ml
Testosterone enanthate is indicated for replacement therapy
in the male in conditions associated with symptoms of
deficiency or absence of endogenous testosterone.
Trenbolone mix is indicated for treatment of
androgen deficiency, wasting syndromes and
muscle atrophy, and certain types of anemia.
TRENBOLONE ENANTHATE
Pharmaceutical Form
Strengths
Therapeutic Category
Injectable
200 mg/ml
Trenbolone enanthate is indicated for treatment of
androgen deficiency, wasting syndromes and
muscle atrophy, and certain types of anemia.
DROSTANOLONE ENANTHATE
Pharmaceutical Form
Strengths
Therapeutic Category
Injectable
200 mg/ml
Drostanolone enanthate is indicated complex therapy for
some kind of tumors, particularly the ones associated
with hormone-active tissues like breast or prostate cancer.
NANDROLONE DECANOATE
Pharmaceutical Form
Strengths
Therapeutic Category
Injectable
250 mg/ml
Nandrolone decanoate is indicated for management
of the anemia of renal insufficiency and has been
shown to increase hemoglobin and red cell mass.
Testosterone mix is indicated for replacement therapy in the
male in conditions associated with symptoms of
deficiency or absence of endogenous testosterone.
